Repare Therapeutics Shareholders May be Entitled to Additional Compensation for Sale to XenoTherapeutics
TL;DR
Halper Sadeh LLC is investigating if Repare Therapeutics' sale to XenoTherapeutics is fair to shareholders, who may receive $1.82 per share plus rights. Shareholders are urged to learn about legal options.
Tags
Halper Sadeh LLC is investigating whether the sale of Repare Therapeutics Inc. to XenoTherapeutics is fair to Repare shareholders. The proposed transaction will result in a cash payment of $1.82 per share plus contingent value rights. Halper Sadeh encourages Repare shareholders to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [[email protected]](mailto:[email protected]). The investigation concerns whether Repare and its board of directors violated federal securities laws and/or breached fiduciary duties.
